Literature DB >> 3585265

Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.

A D Bower, G L Burkett.   

Abstract

A survey of a national sample of family physicians was undertaken to investigate several aspects of attitudes and prescribing patterns related to generic drugs. Questionnaires were returned by 317 of 501 eligible respondents for a response rate of 63.3 percent. Of the respondents, 62.5 percent said they had enough confidence in generic drugs to prescribe them in their practices, but only 26.9 percent said they actually prescribed mostly generics. Respondents were also asked to indicate the relative importance of several potential sources of information on new drugs and to test their ability to recognize a list of generic and trade name drugs. Several associations were identified between physicians' sources of drug information and generic drug recognition, attitudes, and prescription patterns. The habit of prescribing mostly generic drugs, for example, was found to be more common among family physicians who were residency trained, who relied least on drug company representatives, and who were regular readers of the New England Journal of Medicine. The ability to recognize all ten generic names was found to be highest among these same groups of physicians and also among those who relied least on journal advertisements and those who were regular readers of The Medical Letter.

Mesh:

Year:  1987        PMID: 3585265

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  24 in total

1.  Impact of an evidence-based computerized decision support system on primary care prescription costs.

Authors:  S Troy McMullin; Thomas P Lonergan; Charles S Rynearson; Thomas D Doerr; Paul A Veregge; Edward S Scanlan
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

2.  Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility?

Authors:  Karolina Andersson; Anders Carlsten; Tove Hedenrud
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  The proprietary/generic debate.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1991-11

4.  The association between a journal's source of revenue and the drug recommendations made in the articles it publishes.

Authors:  Annette Becker; Fatma Dörter; Kirsten Eckhardt; Annika Viniol; Erika Baum; Michael M Kochen; Joel Lexchin; Karl Wegscheider; Norbert Donner-Banzhoff
Journal:  CMAJ       Date:  2011-02-28       Impact factor: 8.262

5.  Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.

Authors:  M D Sergeant; P G Hodgetts; M Godwin; D M Walker; P McHenry
Journal:  CMAJ       Date:  1996-11-01       Impact factor: 8.262

Review 6.  What information do physicians receive from pharmaceutical representatives?

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

7.  Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.

Authors:  T Shimbo; K Hira; M Takemura; T Fukui
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 8.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262

9.  Physicians and drug companies interact.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

Review 10.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.